Skip to main content
. Author manuscript; available in PMC: 2013 Jul 1.
Published in final edited form as: J Am Acad Dermatol. 2011 Jun 16;67(1):e17–e27. doi: 10.1016/j.jaad.2011.04.008

Table IV.

Comparison of clinical outcomes of our study and those from other working groups

Authors Lesions - Patients (number) Mean lesions/patient Median follow up (months) Excisions (%) out of lesions registered Ratio MM/No MM MM (%)out of excisions Patients diagnosed with MM during DFU (%)
Haenssle6,72010, Germany 11137-688 16.18 46 10.9 1:8.5 10.4 11.4
Argenziano292008, Italy 600 – 405 1.48 23 9 1: 3.4 22.2 3
Fuller42007, USA 5945 – 297 20 22m 5.4 1:53 1.9 2
PRL1:95/NPRL
1:34.4		 PRL 1.1/NPRL
2.75
Haenssle252006, Germany 7001 – 530 13.2 32.2 9.1 1:12 8.3 10
Bauer262003, Germany (EPL) 2015 – 196 10.28 25m 1.6 1: 15.5 6.1 1
Robinson272004, USA 3482 - 100 34.82 36.2 5.5 1: 47.3 2.1 4
Malvehy52002, Barcelona 3170 – 290 10.93 17.2 1.3 1: 4.2 19 2.8
Menzies302001, Australia 318 -245 1.29 3m 19.2 1: 7.7 11.5 2.9
Kittler282000, Austria 1862 – 202 9.21 12.6 4 1: 8.4 10.7 4
Present study 11396-618 18.44 96 10.1 1:10.7 8.5 12.6
PRL 1:11.9/NPRL
1:8.8		 PRL 7.7/NPRL
10.1

PRL: previously registered lesions; NPRL: non previously registered lesions